97 Viral samples collected from dozens of covid patients suggest that Merck & Co.’s new anti-viral covid drug Lagevrio (molnupiravir) is triggering the formation of new “strains” of the disease. (www.eutimes.net) posted 1 year ago by ChiefWoody2021 1 year ago by ChiefWoody2021 +97 / -0 Merck's new covid pill linked to virus mutations, study finds Viral samples collected from dozens of covid patients suggest that Merck & Co.’s new anti-viral covid drug Lagevrio (molnupiravir) is triggering the formation of new “strains” of the disease. A preprint study compiled by researchers from the U.S.-based Fra... 4 comments share 4 comments share save hide report block hide replies
Wait until people find out that all big pharma does is make people sicker for profit